Cardiovascular and Hematological Disorders - Drug Targets

eISSN: 2212-4063 pISSN: 1871-529X

Key Metrics

2.6
CiteScore
0.4
SNIP

Journal Specifications

Overview
Publisher BENTHAM SCIENCE PUBL LTD
Frequency Semi-annual
General Details
Frequency Semi-annual
Publisher URL Visit website
Website URL Visit website

Planning to publish in Cardiovascular and Hematological Disorders - Drug Targets ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations

Looking for the right journals to submit your mansucript?

Upload your manuscript and get a submission readiness score and other journal recommendations.

Check my Paper

Recently Published Papers

Scite analysis

Powered by scite_

554 articles received 4.6k citations see all

  • 104 Supporting
  • 4,320 Mentioning
  • 3 Contrasting

Editorial notices

  • 0 Retractions
  • 0 Withdrawals
  • 0 Corrections
  • 0 Errata
  • 0 Expression of Concern

FAQs

What is the publishing frequency of Cardiovascular and Hematological Disorders - Drug Targets ?

Cardiovascular and Hematological Disorders - Drug Targets published with a Semi-annual frequency.

How many articles did Cardiovascular and Hematological Disorders - Drug Targets publish last years ?

In 2023, Cardiovascular and Hematological Disorders - Drug Targets published 2 articles.

What is the eISSN & pISSN for Cardiovascular and Hematological Disorders - Drug Targets ?

For Cardiovascular and Hematological Disorders - Drug Targets,eISSN is 2212-4063 and pISSN is1871-529X.

What is Citescore for Cardiovascular and Hematological Disorders - Drug Targets ?

Citescore for Cardiovascular and Hematological Disorders - Drug Targets is 2.6.

What is SNIP score for Cardiovascular and Hematological Disorders - Drug Targets ?

SNIP score for Cardiovascular and Hematological Disorders - Drug Targets is 0.4.

Who is the publisher of Cardiovascular and Hematological Disorders - Drug Targets ?

BENTHAM SCIENCE PUBL LTD is the publisher of Cardiovascular and Hematological Disorders - Drug Targets.